Issue Date

2016

Abstract

This study aims to determine the prevalence of asymmetric hearing loss (AHL) and late onset hearing loss (LOHL) in pediatric cancer patients treated with cisplatin and the risk factors for both AHL and LOHL. This study will also examine the relationship between AHL and LOHL.

Language

English

Publisher

Program in Audiology and Communication Sciences, Washington University School of Medicine

Subject (MeSH)

Hearing Loss; Cisplatin; Cancer Survivors; Neoplasms; Child

Document Type

Thesis

Advisor

Hayashi, Robert; Hayashi, Sue

Available for download on Tuesday, September 29, 2020

Share

COinS